Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 1, 2011, Pages 74-81

  De Leeuw, J ^a,b   Assen, Y J ^a   Van Der Beek, N ^b,c,d   Bjerring, P ^e   Martino Neumann, H A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ZBC MultiCare   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d SWANSEA UNIVERSITY   (United Kingdom)

^e SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

blister roof transplantation; khellin; liposomes; ultraviolet light; vitiligo

Indexed keywords

KHELLIN; LIPOSOME;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENCAPSULATION; FEMALE; HAIR FOLLICLE; HUMAN; MALE; MELANOCYTE; PATIENT SATISFACTION; PRIORITY JOURNAL; SKIN PIGMENTATION; TRANSPLANTATION; TREATMENT OUTCOME; ULTRAVIOLET RADIATION; VITILIGO;

ADULT; AGED; CELL TRANSPLANTATION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KHELLIN; LIPOSOMES; MALE; MELANOCYTES; MIDDLE AGED; PATIENT SATISFACTION; VITILIGO;

EID: 78649995911     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03701.x     Document Type: Article

References (37)

1. Kovacs S,. Continuing medical education: vitiligo. J Am Acad Dermatol 1998; 38: 647-666.
2. Kent G, Al-Abadie M,. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996; 21: 330-333.
3. Parsad D, Pandhi R, Dogra S,. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol 2003; 148: 373-374.
4. Sampogna F, Picardi A, Chren MM,. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004; 66: 620-624.
5. Ongenae K, Van Geel N, De Schepper S, Naeyaert JM,. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 2005; 152: 1165-1172.
6. Falabella R,. Surgical treatment of vitiligo: why, when and how. J Eur Acad Dermatol Venereol 2003; 17: 518-520.
7. Cui J, Shen L, Wang G,. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991; 97: 410-416.
8. Westerhof W, Nieuweboer-Krobotova L,. Treatment of vitiligo with UV-B (311 nm) radiation versus topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-1528.
9. Njoo MD, Bos JD, Westerhof W,. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
10. Antoniou G, Katsambas A,. Guidelines for the treatment of vitiligo. Drugs 1992; 43: 490-498.
11. Gawkrodger DJ, Ormerod AD, Shaw L, et al. Guideline for the diagnosis and management of vitiligo. Brit J Dermatol 2008; 159: 1051-1076.
12. Morliere P, Hönigsmann H, Averbeck D, et al. Phototherapeutic, photobiologic and photosensitizing properties of khellin. J Invest Derm 1988; 90: 720-724.
13. Ortel B, Tanew A, Honigsmann H,. Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol 1988; 18: 693-701.
14. Riccio ML, Coratza G, Bovalini L, Martelli P,. Investigation of the mutagenic activity in Salmonella typhimurium of the furochromone khellin, proposed as a therapeutic agent for skin diseases. Mutat Res 1992; 279: 103-108.
15. Schimmer O,. Studies on the photobiological activity of two naturally occurring furochromones, visnagin and khellin, in Chlamydomonas reinhardtii. Mutagenesis 1997; 12: 141-145.
16. Abdel-Fattah A, Aboul-Enein MN, Wassel GM, El-Menshawi BS,. An approach to treatment of vitiligo by khellin. Dermatologica 1982; 165: 136-140.
17. Procaccini EM, Riccio G, Montfrecola G,. Ineffectiveness of topical khellin in photochemotherapy of vitiligo. J Dermatol Treatment 1995; 6: 117-120.
18. Orecchia G, Perfetti L,. Photochemotherapy with topical khellin and sunlight in vitiligo. Dermatology 1992; 184: 120-123.
19. Orecchia G, Sangalli ME, Gazzaniga A, Giordano F,. Topical photochemotherapy of vitiligo with a new khellin formulation: preliminary results. J Dermatol Treatment 1998; 9: 65-69.
20. Valkova S, Trashlieva M, Christova P,. Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA. Clin Exp Dermatol 2004; 29: 180-184.
21. Hope MJ, Kitson CN,. Liposomes: a perspective for dermatologists. Dermatol Clin 1993; 11: 143-154.
22. Egbaria K, Weiner N,. Liposomes as a drug delivery system. Adv Drug Del Syst 1990; 5: 287-300.
23. Lieb L, Ramchandran C, Egbaria K, Weiner N,. Topical delivery enhancement with multilamellar liposomes into pilosebaceous units. J Invest Dermat 1992; 99: 108-113.
24. Hoffman RM,. Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles. J Drug Target 1998; 5: 67-74.
25. Olsson MJ,. What are the needs for transplantation treatment in vitiligo, and how good is it? Arch Dermatol 2004; 140: 1273-1274.
26. Parsad D, Gupta S,. Standard guidelines of care for vitiligo surgery. Indian J Dermatol Venereol Leprol 2008; 74: s37-s45.
27. Hofer A, Karl H, Wolf P,. Long-term results in the treatment of vitiligo with oral khellin plus UVA. Eur J Dermatol 2001; 11: 225-229.
28. De Leeuw J, Van Der Beek N, Maierhofer G, Neugebauer WD,. A case study to evaluate the treatment of vitiligo with khellin encapsulated in L-phenylalanine stabilized phosphatidylcholine liposomes in combination with ultraviolet light therapy. Eur J Dermat 2003; 13: 474-477.
29. Falabella R,. Surgical therapies for vitiligo. Clin Dermatol 1997; 15: 927-939.
30. Gupta S, Jain VK, Saraswat PK,. Suction blister epidermal grafting versus punch skin grafting in recalcitrant and stable vitiligo. Dermatol Surg 1999; 25: 955-958.
31. Gupta S, Kumar B,. Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome. J Am Acad Dermatol 2003; 49: 99-104.
32. Hann SK, Im S, Bong HW, Park YK,. Treatment of stable vitiligo with autologous epidermal grafting and PUVA. J Am Acad Dermatol, 1995; 32: 943-948.
33. Oh CK, Cha JH, Lim JY, Jo JH, Kim SJ,. Treatment of vitiligo with suction epidermal grafting by the use of an ultrapulse CO2 laser with a computerized pattern generator. Dermatol Surg, 2001; 27: 565-568.
34. Pai GS, Vinod V, Joshi A,. Efficacy of erbium YAG laser-assisted autologous epidermal grafting in vitiligo. J Eur Acad Dermatol Venereol, 2002; 16: 604-606.
35. Awad SS, Abdel-Raof H, Hosam El-Din W, El-Domyati M,. Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate. J Cosmet Dermatol 2007; 6: 119-124.
36. Ongenae K, Beelaert L, Van GeelN, Naeyaert J-M,. Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol, 2006; 20: 1-8.
37. Wakkee M, Thio HB,. Neumann HAM. Efalizumab: effectief bij vitiligo?. Ned T Dermatol Venereol 2008; 18: 131-132.